Design and methodology of the screening for CKD among older patients across Europe (SCOPE) study: a multicenter cohort observational study

SCOPE investigators

Research output: Contribution to journalArticle

Abstract

BACKGROUND: Decline of renal function is common in older persons and the prevalence of chronic kidney disease (CKD) is rising with ageing. CKD affects different outcomes relevant to older persons, additionally to morbidity and mortality which makes CKD a relevant health burden in this population. Still, accurate laboratory measurement of kidney function is under debate, since current creatinine-based equations have a certain degree of inaccuracy when used in the older population. The aims of the study are as follows: to assess kidney function in a cohort of 75+ older persons using existing methodologies for CKD screening; to investigate existing and innovative biomarkers of CKD in this cohort, and to align laboratory and biomarker results with medical and functional data obtained from this cohort. The study was registered at ClinicalTrials.gov, identifier NCT02691546, February 25th 2016.

METHODS/DESIGN: An observational, multinational, multicenter, prospective cohort study in community dwelling persons aged 75 years and over, visiting the outpatient clinics of participating institutions. The study will enroll 2450 participants and is carried out in Austria, Germany, Israel, Italy, the Netherlands, Poland and Spain. Participants will undergo clinical and laboratory evaluations at baseline and after 12 and 24 months- follow-up. Clinical evaluation also includes a comprehensive geriatric assessment (CGA). Local laboratory will be used for 'basic' parameters (including serum creatinine and albumin-to-creatinine ratio), whereas biomarker assessment will be conducted centrally. An intermediate telephone follow-up will be carried out at 6 and 18 months.

DISCUSSION: Combining the use of CGA and the investigation of novel and existing independent biomarkers within the SCOPE study will help to provide evidence in the development of European guidelines and recommendations in the screening and management of CKD in older people.

TRIAL REGISTRATION: This study was registered prospectively on the 25th February 2016 at clinicaltrials.gov ( NCT02691546 ).

Original languageEnglish
Pages (from-to)260
JournalBMC Nephrology
Volume19
Issue number1
DOIs
Publication statusPublished - Oct 11 2018

Fingerprint

Chronic Renal Insufficiency
Multicenter Studies
Observational Studies
Cohort Studies
Biomarkers
Geriatric Assessment
Creatinine
Kidney
Independent Living
Austria
Israel
Poland
Ambulatory Care Facilities
Telephone
Serum Albumin
Netherlands
Spain
Italy
Population
Germany

Cite this

Design and methodology of the screening for CKD among older patients across Europe (SCOPE) study : a multicenter cohort observational study. / SCOPE investigators.

In: BMC Nephrology, Vol. 19, No. 1, 11.10.2018, p. 260.

Research output: Contribution to journalArticle

@article{6d6325adc72c44a4abfb10f8656df7fc,
title = "Design and methodology of the screening for CKD among older patients across Europe (SCOPE) study: a multicenter cohort observational study",
abstract = "BACKGROUND: Decline of renal function is common in older persons and the prevalence of chronic kidney disease (CKD) is rising with ageing. CKD affects different outcomes relevant to older persons, additionally to morbidity and mortality which makes CKD a relevant health burden in this population. Still, accurate laboratory measurement of kidney function is under debate, since current creatinine-based equations have a certain degree of inaccuracy when used in the older population. The aims of the study are as follows: to assess kidney function in a cohort of 75+ older persons using existing methodologies for CKD screening; to investigate existing and innovative biomarkers of CKD in this cohort, and to align laboratory and biomarker results with medical and functional data obtained from this cohort. The study was registered at ClinicalTrials.gov, identifier NCT02691546, February 25th 2016.METHODS/DESIGN: An observational, multinational, multicenter, prospective cohort study in community dwelling persons aged 75 years and over, visiting the outpatient clinics of participating institutions. The study will enroll 2450 participants and is carried out in Austria, Germany, Israel, Italy, the Netherlands, Poland and Spain. Participants will undergo clinical and laboratory evaluations at baseline and after 12 and 24 months- follow-up. Clinical evaluation also includes a comprehensive geriatric assessment (CGA). Local laboratory will be used for 'basic' parameters (including serum creatinine and albumin-to-creatinine ratio), whereas biomarker assessment will be conducted centrally. An intermediate telephone follow-up will be carried out at 6 and 18 months.DISCUSSION: Combining the use of CGA and the investigation of novel and existing independent biomarkers within the SCOPE study will help to provide evidence in the development of European guidelines and recommendations in the screening and management of CKD in older people.TRIAL REGISTRATION: This study was registered prospectively on the 25th February 2016 at clinicaltrials.gov ( NCT02691546 ).",
author = "{SCOPE investigators} and Andrea Corsonello and Lisanne Tap and Regina Roller-Wirnsberger and Gerhard Wirnsberger and Carmine Zoccali and Tomasz Kostka and Agnieszka Guligowska and Francesco Mattace-Raso and Pedro Gil and Fuentes, {Lara Guardado} and Itshak Meltzer and Ilan Yehoshua and Francesc Formiga-Perez and Rafael Moreno-Gonz{\'a}lez and Christian Weingart and Ellen Freiberger and Johan {\"A}rnl{\"o}v and Carlsson, {Axel C} and Silvia Bustacchini and Fabrizia Lattanzio",
year = "2018",
month = "10",
day = "11",
doi = "10.1186/s12882-018-1030-2",
language = "English",
volume = "19",
pages = "260",
journal = "BMC Nephrology",
issn = "1471-2369",
publisher = "BMC",
number = "1",

}

TY - JOUR

T1 - Design and methodology of the screening for CKD among older patients across Europe (SCOPE) study

T2 - a multicenter cohort observational study

AU - SCOPE investigators

AU - Corsonello, Andrea

AU - Tap, Lisanne

AU - Roller-Wirnsberger, Regina

AU - Wirnsberger, Gerhard

AU - Zoccali, Carmine

AU - Kostka, Tomasz

AU - Guligowska, Agnieszka

AU - Mattace-Raso, Francesco

AU - Gil, Pedro

AU - Fuentes, Lara Guardado

AU - Meltzer, Itshak

AU - Yehoshua, Ilan

AU - Formiga-Perez, Francesc

AU - Moreno-González, Rafael

AU - Weingart, Christian

AU - Freiberger, Ellen

AU - Ärnlöv, Johan

AU - Carlsson, Axel C

AU - Bustacchini, Silvia

AU - Lattanzio, Fabrizia

PY - 2018/10/11

Y1 - 2018/10/11

N2 - BACKGROUND: Decline of renal function is common in older persons and the prevalence of chronic kidney disease (CKD) is rising with ageing. CKD affects different outcomes relevant to older persons, additionally to morbidity and mortality which makes CKD a relevant health burden in this population. Still, accurate laboratory measurement of kidney function is under debate, since current creatinine-based equations have a certain degree of inaccuracy when used in the older population. The aims of the study are as follows: to assess kidney function in a cohort of 75+ older persons using existing methodologies for CKD screening; to investigate existing and innovative biomarkers of CKD in this cohort, and to align laboratory and biomarker results with medical and functional data obtained from this cohort. The study was registered at ClinicalTrials.gov, identifier NCT02691546, February 25th 2016.METHODS/DESIGN: An observational, multinational, multicenter, prospective cohort study in community dwelling persons aged 75 years and over, visiting the outpatient clinics of participating institutions. The study will enroll 2450 participants and is carried out in Austria, Germany, Israel, Italy, the Netherlands, Poland and Spain. Participants will undergo clinical and laboratory evaluations at baseline and after 12 and 24 months- follow-up. Clinical evaluation also includes a comprehensive geriatric assessment (CGA). Local laboratory will be used for 'basic' parameters (including serum creatinine and albumin-to-creatinine ratio), whereas biomarker assessment will be conducted centrally. An intermediate telephone follow-up will be carried out at 6 and 18 months.DISCUSSION: Combining the use of CGA and the investigation of novel and existing independent biomarkers within the SCOPE study will help to provide evidence in the development of European guidelines and recommendations in the screening and management of CKD in older people.TRIAL REGISTRATION: This study was registered prospectively on the 25th February 2016 at clinicaltrials.gov ( NCT02691546 ).

AB - BACKGROUND: Decline of renal function is common in older persons and the prevalence of chronic kidney disease (CKD) is rising with ageing. CKD affects different outcomes relevant to older persons, additionally to morbidity and mortality which makes CKD a relevant health burden in this population. Still, accurate laboratory measurement of kidney function is under debate, since current creatinine-based equations have a certain degree of inaccuracy when used in the older population. The aims of the study are as follows: to assess kidney function in a cohort of 75+ older persons using existing methodologies for CKD screening; to investigate existing and innovative biomarkers of CKD in this cohort, and to align laboratory and biomarker results with medical and functional data obtained from this cohort. The study was registered at ClinicalTrials.gov, identifier NCT02691546, February 25th 2016.METHODS/DESIGN: An observational, multinational, multicenter, prospective cohort study in community dwelling persons aged 75 years and over, visiting the outpatient clinics of participating institutions. The study will enroll 2450 participants and is carried out in Austria, Germany, Israel, Italy, the Netherlands, Poland and Spain. Participants will undergo clinical and laboratory evaluations at baseline and after 12 and 24 months- follow-up. Clinical evaluation also includes a comprehensive geriatric assessment (CGA). Local laboratory will be used for 'basic' parameters (including serum creatinine and albumin-to-creatinine ratio), whereas biomarker assessment will be conducted centrally. An intermediate telephone follow-up will be carried out at 6 and 18 months.DISCUSSION: Combining the use of CGA and the investigation of novel and existing independent biomarkers within the SCOPE study will help to provide evidence in the development of European guidelines and recommendations in the screening and management of CKD in older people.TRIAL REGISTRATION: This study was registered prospectively on the 25th February 2016 at clinicaltrials.gov ( NCT02691546 ).

U2 - 10.1186/s12882-018-1030-2

DO - 10.1186/s12882-018-1030-2

M3 - Article

C2 - 30309342

VL - 19

SP - 260

JO - BMC Nephrology

JF - BMC Nephrology

SN - 1471-2369

IS - 1

ER -